Medtronic plc (FRA:2M6)

Market Cap	98.97B
Revenue (ttm)	31.58B
Net Income (ttm)	4.05B
Shares Out	n/a
EPS (ttm)	3.11
PE Ratio	24.43
Forward PE	14.93
Dividend	2.60 (3.48%)
Ex-Dividend Date	Mar 28, 2025

Volume	146
Average Volume	975
Open	74.27
Previous Close	73.62
Day's Range	74.21 - 74.69
52-Week Range	68.50 - 90.89
Beta	n/a
RSI	56.67
Earnings Date	May 21, 2025

About Medtronic

Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. The Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac monitor systems; TYRX products; and remote monitoring and patient-centered software. It also provides aortic valves, surgical valve replacement and repair products, endovascular stent grafts and accesso...

• Industry: Electromedical and Electrotherapeutic Apparatus
• Founded: 1949
• Employees: 95,000
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: 2M6

Financial Performance

In 2024, Medtronic's revenue was $32.36 billion, an increase of 3.64% compared to the previous year's $31.23 billion. Earnings were $3.68 billion, a decrease of -2.18%.

Financial numbers in USD